Patent · US Active

Pyrrolidine-2, 5-dione derivatives, pharmaceutical compositions and methods for use as IDO1 inhibitors

US9949951B2 · kind B2 · utility

1Cited by

3References

24Claims

0Family size

Assignee

iTeos Therapeutics SA · BE

Inventors

Stefano Crosignani · Nivelles, BE
Sandra Cauwenberghs · Halle, BE
Gregory Driessens · Ottignies, BE
Frederik Deroose · Gentbrugge, BE

Key dates

Filing date	Oct 21, 2016
Grant date	Apr 24, 2018
Priority date	—
Expiry date	Oct 21, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Uses of compound of Formula I:or pharmaceutically acceptable enantiomers, salts, solvates or prodrugs thereof are described. The compounds of Formula I are useful as IDO1 inhibitors. These are also useful for the treatment and/or prevention of cancer and endometriosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.